Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy
07/10/2026 13:19
BRIEF-Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy Oct 7 (Reuters) - Lipocine Inc LPCN.O:
LIPOCINE ANNOUNCES HEALTH CANADA APPROVAL OF TLANDO® FOR TESTOSTERONE REPLACEMENT THERAPY
Source text: ID:nPnbFgl2wa
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy